The is the strain card and all its information available in our database. Thhe information includes the result of experiemtnal epitope mapping and prediction from various algorithms. Experimental epitopes were mapped from IEDB repository were B cell, T cell and MHC binders. The prediction tools including B cell epitope (LBtope), MHC class I binding alleles (Propred1), MHC class II binding alleles (Propred), CTL epitope (CTLpred), HLA alleles (nHLApred), interferon-gamma inducing potential (IFNepitope), Interleukin-4 inducing capacity (IL4pred).
Strain
M_indicus_prani_MTCC_9506
Description
Mycobacterium indicus pranii (MIP), a taxonomically unknown generalist mycobacterium, acts as an immunotherapeutic against leprosy and is approved for use as a vaccine against it. MIP, commercially available as Immuvac, is currently the focus of advanced phase III clinical trials for its antituberculosis efficacy.